BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
BioInvent International Max Drawdown (5Y): 62.75% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 62.75% |
| March 31, 2024 | 62.75% |
| February 29, 2024 | 64.06% |
| January 31, 2024 | 64.06% |
| December 31, 2023 | 64.06% |
| November 30, 2023 | 64.06% |
| October 31, 2023 | 64.06% |
| September 30, 2023 | 64.06% |
| August 31, 2023 | 64.06% |
| July 31, 2023 | 64.06% |
| June 30, 2023 | 64.06% |
| May 31, 2023 | 64.06% |
| April 30, 2023 | 64.06% |
| March 31, 2023 | 64.06% |
| February 28, 2023 | 64.06% |
| January 31, 2023 | 64.06% |
| December 31, 2022 | 64.06% |
| November 30, 2022 | 64.06% |
| October 31, 2022 | 64.06% |
| September 30, 2022 | 64.06% |
| August 31, 2022 | 64.06% |
| July 31, 2022 | 64.06% |
| June 30, 2022 | 64.06% |
| May 31, 2022 | 64.06% |
| April 30, 2022 | 64.06% |
| Date | Value |
|---|---|
| March 31, 2022 | 64.06% |
| February 28, 2022 | 64.06% |
| January 31, 2022 | 64.06% |
| December 31, 2021 | 64.06% |
| November 30, 2021 | 64.06% |
| October 31, 2021 | 64.06% |
| September 30, 2021 | 90.10% |
| August 31, 2021 | 90.10% |
| July 31, 2021 | 90.10% |
| June 30, 2021 | 90.10% |
| May 31, 2021 | 90.10% |
| April 30, 2021 | 90.10% |
| March 31, 2021 | 90.10% |
| February 28, 2021 | 90.10% |
| January 31, 2021 | 90.10% |
| December 31, 2020 | 90.35% |
| November 30, 2020 | 90.35% |
| October 31, 2020 | 90.35% |
| September 30, 2020 | 90.35% |
| August 31, 2020 | 90.35% |
| July 31, 2020 | 90.35% |
| June 30, 2020 | 90.35% |
| May 31, 2020 | 90.35% |
| April 30, 2020 | 90.35% |
| March 31, 2020 | 90.35% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
62.75%
Minimum
Mar 2024
91.50%
Maximum
May 2019
76.78%
Average
64.06%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Abliva AB | 99.34% |
| Karolinska Development AB | -- |
| Calliditas Therapeutics AB | -- |
| Oncopeptides AB | -- |
| Olink Holding AB | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -8.468 |
| Beta (5Y) | 0.7329 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 47.13% |
| Historical Sharpe Ratio (5Y) | -0.0064 |
| Historical Sortino (5Y) | -0.0104 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.98% |